• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质子泵抑制剂与社区药房:使用情况和与长期使用相关的因素。

Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use.

机构信息

Post-Graduate Program in Pharmaceutical Sciences, Health Sciences Center, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil.

Pharmacy Department, Health Sciences Center, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil.

出版信息

PLoS One. 2021 Jun 10;16(6):e0252785. doi: 10.1371/journal.pone.0252785. eCollection 2021.

DOI:10.1371/journal.pone.0252785
PMID:34111166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8191994/
Abstract

AIM

To characterize the usage profile and the factors associated with the prolonged use of proton pump inhibitor drugs in a community pharmacy.

METHODOLOGY

This is a cross-sectional, prospective and observational study involving interviews with 410 patients who acquired PPI for their own use from community pharmacies. To characterize the factors associated with the prolonged use of PPI, a multivariate logistic regression model was used.

RESULTS

Pantoprazole (42.7%) and omeprazole (31%) were the most acquired PPIs, prescribed mainly by gastroenterologists (49.5%). They are used in the morning, especially for gastrointestinal symptoms, however, they had been consumed for more than 5 years in 30% of cases. The factors associated with prolonged use are old age (OR 1.03 CI95% 1.01-1.05), body mass index (OR 1.07 CI95% 1.01-1.12), use of non-steroidal anti-inflammatories (OR 3.18 CI95% 1.20-8.43) and selective serotonin reuptake inhibitors (OR 3.5 95% CI 1.39-8.88).

CONCLUSION

PPIs are adequate in terms of indication and form of use, however, prolonged use associated with old age, being overweight and use of anti-inflammatories and antidepressants is frequent.

摘要

目的

描述社区药店中质子泵抑制剂(PPI)药物长期使用的使用情况和相关因素。

方法

这是一项横断面、前瞻性和观察性研究,涉及对 410 名从社区药店自行购买 PPI 的患者进行访谈。为了描述与 PPI 长期使用相关的因素,使用了多变量逻辑回归模型。

结果

泮托拉唑(42.7%)和奥美拉唑(31%)是最常被获取的 PPI,主要由胃肠病学家开具(49.5%)。它们在早上使用,特别是用于胃肠道症状,但在 30%的情况下已经使用了超过 5 年。与长期使用相关的因素是年龄较大(OR 1.03 CI95% 1.01-1.05)、体重指数(OR 1.07 CI95% 1.01-1.12)、使用非甾体抗炎药(OR 3.18 CI95% 1.20-8.43)和选择性 5-羟色胺再摄取抑制剂(OR 3.5 95% CI 1.39-8.88)。

结论

PPI 在适应证和使用方式方面是适当的,但是与年龄较大、超重以及使用抗炎药和抗抑郁药相关的长期使用是常见的。

相似文献

1
Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use.质子泵抑制剂与社区药房:使用情况和与长期使用相关的因素。
PLoS One. 2021 Jun 10;16(6):e0252785. doi: 10.1371/journal.pone.0252785. eCollection 2021.
2
Evidence-based and unlicensed indications for proton pump inhibitors and patients' preferences for discontinuation: a pilot study in a sample of Italian community pharmacies.质子泵抑制剂的循证与非许可适应证及患者停药偏好:意大利社区药房样本的一项试点研究
J Clin Pharm Ther. 2016 Apr;41(2):220-3. doi: 10.1111/jcpt.12371. Epub 2016 Mar 2.
3
Prescribing of proton pump inhibitors for gastrointestinal bleeding prophylaxis in the Lebanese outpatient setting: patterns, compliance with guidelines and risks.黎巴嫩门诊环境中用于预防胃肠道出血的质子泵抑制剂的处方:模式、指南遵循情况及风险
Int J Pharm Pract. 2019 Aug;27(4):386-392. doi: 10.1111/ijpp.12537. Epub 2019 Apr 3.
4
Safety of the long-term use of proton pump inhibitors.质子泵抑制剂长期使用的安全性。
World J Gastroenterol. 2010 May 21;16(19):2323-30. doi: 10.3748/wjg.v16.i19.2323.
5
Prolonged utilization of proton pump inhibitors in patients with ischemic and valvular heart disease is associated with surgical treatments, weight loss and aggravates anemia.缺血性和瓣膜性心脏病患者长期使用质子泵抑制剂与手术治疗、体重减轻有关,并会加重贫血。
Int J Cardiol. 2016 Sep 15;219:277-81. doi: 10.1016/j.ijcard.2016.06.058. Epub 2016 Jun 19.
6
Inhibition of lysosomal enzyme activities by proton pump inhibitors.质子泵抑制剂对溶酶体酶活性的抑制作用。
J Gastroenterol. 2013 Dec;48(12):1343-52. doi: 10.1007/s00535-013-0774-5. Epub 2013 Mar 12.
7
Proton pump inhibitor co-prescription with dual antiplatelet therapy among patients with acute coronary syndrome in Qatar.卡塔尔急性冠状动脉综合征患者中质子泵抑制剂与双重抗血小板治疗的联合处方情况。
Int J Clin Pharm. 2016 Apr;38(2):353-61. doi: 10.1007/s11096-016-0250-4. Epub 2016 Jan 9.
8
Co-prescribing of proton pump inhibitors among chronic users of NSAIDs in the UK.英国非甾体抗炎药长期使用者中质子泵抑制剂的联合处方情况。
Rheumatology (Oxford). 2008 Apr;47(4):458-63. doi: 10.1093/rheumatology/kem375. Epub 2008 Feb 7.
9
Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.1997年至2012年爱尔兰基层医疗中老年人质子泵抑制剂潜在不适当处方的特征分析
J Am Geriatr Soc. 2016 Dec;64(12):e291-e296. doi: 10.1111/jgs.14528. Epub 2016 Nov 7.
10
Outcomes of a decision support prompt in community pharmacy-dispensing software to promote step-down of proton pump inhibitor therapy.促进质子泵抑制剂治疗降级的社区药房配药软件中的决策支持提示的结果。
Br J Clin Pharmacol. 2011 May;71(5):780-4. doi: 10.1111/j.1365-2125.2010.03890.x.

引用本文的文献

1
Knowledge, Attitudes, and Practices of Community Pharmacists Regarding Proton Pump Inhibitor (PPI) Use: A Cross-Sectional Study.社区药剂师对质子泵抑制剂(PPI)使用的知识、态度和实践:一项横断面研究。
Healthcare (Basel). 2025 Jul 2;13(13):1588. doi: 10.3390/healthcare13131588.
2
Ensuring safe and effective pharmacotherapy: The role of "community pharmacology" in attaining "health for all" from the Indian perspective.确保安全有效的药物治疗:从印度视角看“社区药理学”在实现“全民健康”中的作用。
J Family Med Prim Care. 2024 Dec;13(12):5465-5471. doi: 10.4103/jfmpc.jfmpc_1226_24. Epub 2024 Dec 9.
3
Association of suicidal ideation and depression with the use of proton pump inhibitors in adults: a cross-sectional study.自杀意念和抑郁与成年人使用质子泵抑制剂的相关性:一项横断面研究。
Sci Rep. 2022 Nov 14;12(1):19539. doi: 10.1038/s41598-022-24244-z.

本文引用的文献

1
National Cross-Sectional Study of Community-Based Adverse Drug Reactions in Saudi Arabia.沙特阿拉伯基于社区的药物不良反应全国横断面研究。
Drugs Real World Outcomes. 2020 Jun;7(2):161-170. doi: 10.1007/s40801-020-00186-8.
2
Direct-To-Consumer Advertising of Over-the-Counter Sinonasal Remedies: A History of Mixed Messages.直接面向消费者的非处方鼻腔鼻窦制剂广告:混合信息的历史。
Laryngoscope. 2020 Sep;130(9):2114-2119. doi: 10.1002/lary.28366. Epub 2019 Oct 25.
3
Adverse Effects of Proton Pump Inhibitors-Evidence and Plausibility.质子泵抑制剂的不良反应——证据与可能性。
Int J Mol Sci. 2019 Oct 21;20(20):5203. doi: 10.3390/ijms20205203.
4
The Safety of Long-term Daily Usage of a Proton Pump Inhibitor: A Literature Review.质子泵抑制剂长期每日使用的安全性:文献综述
Cureus. 2019 Sep 4;11(9):e5563. doi: 10.7759/cureus.5563.
5
Prescribing of Proton Pump Inhibitors in an Irish General Practice.爱尔兰全科医疗中质子泵抑制剂的处方情况
Ir Med J. 2019 May 9;112(5):932.
6
Gastric bypass surgery in the treatment of gastro-oesophageal reflux symptoms.胃旁路手术治疗胃食管反流症状。
Aliment Pharmacol Ther. 2019 Jul;50(2):159-166. doi: 10.1111/apt.15274. Epub 2019 Jun 4.
7
Attitude and knowledge of Saudi community pharmacists towards use of proton pump inhibitors.沙特社区药剂师对质子泵抑制剂使用的态度和知识
Saudi Pharm J. 2019 Feb;27(2):225-228. doi: 10.1016/j.jsps.2018.11.002. Epub 2018 Nov 7.
8
Frequency of use of non-prescribed medication among population sample from Al Madina City and its impact on quality of care in Saudi Arabia.麦地那市人群样本中非处方药的使用频率及其对沙特阿拉伯医疗质量的影响。
Int J Health Sci (Qassim). 2018 Sep-Oct;12(5):3-9.
9
Non-guideline-recommended prescribing of proton pump inhibitors in the general population.普通人群中质子泵抑制剂的非指南推荐处方用药情况。
Curr Med Res Opin. 2017 Oct;33(10):1725-1729. doi: 10.1080/03007995.2017.1308921. Epub 2017 Apr 19.
10
The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.质子泵抑制剂长期使用的风险和益处:美国胃肠病学会的专家评论和最佳实践建议。
Gastroenterology. 2017 Mar;152(4):706-715. doi: 10.1053/j.gastro.2017.01.031.